BANK OF MONTREAL /CAN/ - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 67 filers reported holding IMMUNE DESIGN CORP in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q4 2018$1,0000.0%446
+93.1%
0.00%
Q3 2018$1,0000.0%231
-2.9%
0.00%
Q2 2018$1,000238
+852.0%
0.00%
Q1 2016$0
-100.0%
250.0%0.00%
Q4 2015$1,000250.0%0.00%
Q3 2015$0
-100.0%
250.0%0.00%
Q2 2015$1,0000.0%250.0%0.00%
Q1 2015$1,000250.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q4 2015
NameSharesValueWeighting ↓
Svennilson Peter 6,642,942$8,636,0007.61%
Versant Venture Management, LLC 2,208,210$2,870,673,0001.42%
BVF INC/IL 5,185,383$6,741,0000.88%
EcoR1 Capital, LLC 5,603,191$7,284,0000.73%
Abingworth LLP 352,300$458,0000.42%
Bain Capital Public Equity Management, LLC 892,061$1,160,0000.11%
ALGERT GLOBAL LLC 92,591$120,0000.03%
GSA CAPITAL PARTNERS LLP 41,068$53,0000.01%
OXFORD ASSET MANAGEMENT LLP 136,468$177,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 27,122$35,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders